To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06237920
Title Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab (TURANDORELA)
Acronym TURANDORELA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Netherlands Cancer Institute
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD

Facility Status City State Zip Country Details
Radboud University Medical Center RECRUITING Nijmegen Gelderland 6525GA Netherlands Details
NKI-AVL RECRUITING Amsterdam Noord-Holland 1066CX Netherlands Details
Amsterdam UMC (AUMC) RECRUITING Amsterdam Noord-Holland 1081HV Netherlands Details
Leiden University Medical Center (LUMC) RECRUITING Leiden Zuid-Holland 2333ZA Netherlands Details
Erasmus Medical Center RECRUITING Rotterdam Zuid_Holland 3015GD Netherlands Details
University Medical Center Utrecht RECRUITING Utrecht 3584CX Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field